ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko01524	Platinum drug resistance	3/4	76/7206	4.47662728919e-06
ko05161	Hepatitis B	3/4	173/7206	5.34530419197e-05
ko04210	Apoptosis	3/4	180/7206	6.02039433381e-05
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/4	191/7206	7.19152699585e-05
ko04215	Apoptosis - multiple species	2/4	47/7206	0.000247773464871
ko05210	Colorectal cancer	2/4	86/7206	0.000831696823629
ko04620	Toll-like receptor signaling pathway	2/4	100/7206	0.00112343806738
ko05200	Pathways in cancer	3/4	492/7206	0.00120144872471
ko01521	EGFR tyrosine kinase inhibitor resistance	2/4	106/7206	0.00126160333377
ko04668	TNF signaling pathway	2/4	120/7206	0.001614434015
ko04211	Longevity regulating pathway	2/4	123/7206	0.0016955614292
ko01522	Endocrine resistance	2/4	124/7206	0.00172303540505
ko05142	Chagas disease (American trypanosomiasis)	2/4	130/7206	0.00189240130352
ko04933	AGE-RAGE signaling pathway in diabetic complications	2/4	135/7206	0.00203944753078
ko04722	Neurotrophin signaling pathway	2/4	160/7206	0.00285468083675
ko04071	Sphingolipid signaling pathway	2/4	162/7206	0.00292562381539
ko04217	Necroptosis	2/4	178/7206	0.00352344111444
ko04932	Non-alcoholic fatty liver disease (NAFLD)	2/4	182/7206	0.00368126841669
ko04141	Protein processing in endoplasmic reticulum	2/4	184/7206	0.00376143257369
ko05152	Tuberculosis	2/4	187/7206	0.00388323916279
ko05203	Viral carcinogenesis	2/4	277/7206	0.00839183641541
ko05166	HTLV-I infection	2/4	292/7206	0.00930058206912
ko05020	Prion diseases	1/4	40/7206	0.0220240722516
ko04960	Aldosterone-regulated sodium reabsorption	1/4	41/7206	0.0225699700625
ko04973	Carbohydrate digestion and absorption	1/4	42/7206	0.0231156393042
ko04624	Toll and Imd signaling pathway	1/4	49/7206	0.0269289294399
ko04930	Type II diabetes mellitus	1/4	54/7206	0.0296458650833
ko05213	Endometrial cancer	1/4	62/7206	0.0339811229605
ko04622	RIG-I-like receptor signaling pathway	1/4	62/7206	0.0339811229605
ko05221	Acute myeloid leukemia	1/4	63/7206	0.0345220069906
ko05223	Non-small cell lung cancer	1/4	66/7206	0.036143296333
ko05014	Amyotrophic lateral sclerosis (ALS)	1/4	74/7206	0.0404567523021
ko04115	p53 signaling pathway	1/4	74/7206	0.0404567523021
ko04370	VEGF signaling pathway	1/4	77/7206	0.0420705598294
ko04664	Fc epsilon RI signaling pathway	1/4	77/7206	0.0420705598294
ko04923	Regulation of lipolysis in adipocytes	1/4	77/7206	0.0420705598294
ko05214	Glioma	1/4	79/7206	0.043145300024
ko05230	Central carbon metabolism in cancer	1/4	81/7206	0.044219135619
ko05212	Pancreatic cancer	1/4	83/7206	0.0452920671213
ko05220	Chronic myeloid leukemia	1/4	85/7206	0.0463640950384
ko05218	Melanoma	1/4	85/7206	0.0463640950384
ko04213	Longevity regulating pathway - multiple species	1/4	86/7206	0.0468997703113
ko04657	IL-17 signaling pathway	1/4	87/7206	0.0474352198785
ko04212	Longevity regulating pathway - worm	1/4	87/7206	0.0474352198785
ko04917	Prolactin signaling pathway	1/4	87/7206	0.0474352198785
ko04662	B cell receptor signaling pathway	1/4	88/7206	0.0479704438032
ko05222	Small cell lung cancer	1/4	89/7206	0.0485054421488
ko00562	Inositol phosphate metabolism	1/4	89/7206	0.0485054421488